Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

0.7759
-0.0214-2.68%
Post-market: 0.78870.0128+1.65%19:30 EDT
Volume:1.90M
Turnover:1.50M
Market Cap:228.89M
PE:-2.13
High:0.8151
Open:0.7822
Low:0.7703
Close:0.7973
52wk High:3.07
52wk Low:0.5277
Shares:295.00M
Float Shares:208.00M
Volume Ratio:0.70
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3641
EPS(LYR):-0.3048
ROE:-95.89%
ROA:-45.67%
PB:1.26
PE(LYR):-2.55

Loading ...

Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
May 14

Invivyd Q1 Revenue USD 13.744 Million

THOMSON REUTERS
·
May 14

Invivyd Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 12

Invivyd plans LIBERTY trial comparing VYD2311 tolerability with mRNA COVID vaccine

Reuters
·
May 11

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of Covid Monoclonal Antibody and Comparing Results to Covid Vaccination

THOMSON REUTERS
·
May 11

Invivyd to host first-quarter results, corporate update call

Reuters
·
May 07

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 05

Invivyd chairman Marc Elia speaks at POLITICO Health Care Summit

Reuters
·
Apr 20

Invivyd Announces Chairman Marc Elia to Speak at Politico Health Care Summit

THOMSON REUTERS
·
Apr 20

Invivyd Says Study of Potential COVID-19 Treatment Shows 'High End' Efficacy; Measles Candidate Introduced

MT Newswires Live
·
Apr 09

Invivyd expands Phase 3 VYD2311 COVID prevention trial, shifts results to Q3 2026

Reuters
·
Apr 09

Invivyd Announces Revolution Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate Vms063 for Treatment and Prevention of Measles

THOMSON REUTERS
·
Apr 09

Invivyd announces annual shareholder meeting via webcast

Reuters
·
Apr 07

Invivyd grants inducement stock options for 1.1 million shares to new hires

Reuters
·
Apr 06

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 06

Invivyd CSO presents monoclonal antibody development at World Vaccine Congress Washington

Reuters
·
Mar 31

Invivyd Announces Presentation at the World Vaccine Congress Washington

THOMSON REUTERS
·
Mar 31

Cantor Fitzgerald Remains a Buy on Invivyd (IVVD)

TIPRANKS
·
Mar 23